PMON336 Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES): A multi-country, non-interventional, prospective, cohort study of patients receiving human growth hormone treatments under routine clinical care

BACKGROUND: Children with growth hormone deficiency (GHD) are treated with recombinant human growth hormone (rhGH), usually administered as a daily subcutaneous injection. Long-acting hGH (LAGH) treatments (approved and in development) have the potential to improve adherence and treatment outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Geffner, Mitchell E, Ibanez, Lourdes, Maniatis, Aristides, Torre, Daria L, Huang, Carol, Darendelieler, Feyza, Dattani, Mehul, Maghnie, Mohamad, Phillip, Moshe, Dahlgren, Jovanna, Horikawa, Reiko, Gomez, Roy, Kelly, Scott P, Wajnrajch, Michael P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625236/
http://dx.doi.org/10.1210/jendso/bvac150.1306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625236/
http://dx.doi.org/10.1210/jendso/bvac150.1306

Ejemplares similares